Publications by authors named "N Azli"

Introduction: This study evaluated the level of grit and its association with academic achievement among pharmacy undergraduate students in Malaysia.

Methods: This was a cross-sectional study conducted at a public university in Malaysia. Data were collected using an electronic, validated, pre-tested modified version of the short Grit scale between December 2019 and January 2020.

View Article and Find Full Text PDF

Ascorbic acid was used for the first time to synthesize crystalline starch nanoparticles (CSNP). The physical properties of the CSNP were investigated. Rheological properties of the crystalline starch nanofluid (CSNF) were compared with native cassava starch (CS) and commercial polymer xanthan.

View Article and Find Full Text PDF

Ascorbic acid was used for the first time to synthesize cellulose nanoparticles (CNP) extracted from okra mucilage. The physical properties of the CNP including their size distribution, and crystalline structures were investigated. The rheological properties of the cellulose nanofluid (CNF) were compared with the bulk okra mucilage and commercial polymer xanthan.

View Article and Find Full Text PDF

In this research, natural nanomaterials including cellulose nanocrystal (CNC), nanofiber cellulose (NFC), and synthetic nanoparticles such as carbon nanofiber (CNF) and carbon nanotube (CNT) with different structures, sizes, and surface areas were produced and analyzed. The most significant contribution of this study is to evaluate and compare these nanomaterials based on the effects of their structures and morphologies on their electrochemical, biomedical, and thermal properties. Based on the obtained results, the natural nanomaterials with low dimension and surface area have zero cytotoxicity effects on the living cells at 12.

View Article and Find Full Text PDF

Background: This randomized phase II study was conducted to evaluate the efficacy of doxorubicin and docetaxel (DOC) administered either as a combination, an alternating or a sequential regimen in women with metastatic breast cancer. Secondary objectives included overall response, time to progression, survival and safety.

Patients And Methods: Patients with breast cancer (n=123) were randomized to receive doxorubicin and DOC either in combination (60 mg/m2 of each drug), or by alternated or sequential schedule (100 mg/m2 DOC and 75 mg/m2 doxorubicin) every 3 weeks for a maximum of eight cycles as first chemotherapy for stage IV disease.

View Article and Find Full Text PDF